{"id":"https://openalex.org/A5073729945","orcid":null,"observed_orcids":[],"display_name":"Monica Woloshin","raw_author_names":["Monica Woloshin"],"full_name":"Monica Woloshin","works_count":1,"cited_by_count":9,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":1,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5073729945","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I149251103","ror":"https://ror.org/00ysqcn41","display_name":"Thomas Jefferson University","country_code":"US","type":"education","lineage":["https://openalex.org/I149251103"]},"years":[2021]}],"last_known_institutions":[{"id":"https://openalex.org/I149251103","ror":"https://ror.org/00ysqcn41","display_name":"Thomas Jefferson University","country_code":"US","type":"education","lineage":["https://openalex.org/I149251103"]}],"topics":[{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","count":1,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12246","display_name":"Chronic Disease Management Strategies","count":1,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13970","display_name":"Pharmacy and Medical Practices","count":1,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12246","display_name":"Chronic Disease Management Strategies","value":1.12e-05,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","value":3.8e-06,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13970","display_name":"Pharmacy and Medical Practices","value":2.5e-06,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"2778689640","wikidata":"https://www.wikidata.org/wiki/Q113259","display_name":"Anticholinergic","score":0.881904661655426},{"id":"194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","score":0.4361634850502014},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.34962987899780273},{"id":"118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","score":0.16621994972229004},{"id":"134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","score":0.0}],"counts_by_year":[{"year":2021,"works_count":1,"oa_works_count":0,"cited_by_count":9}],"display_name_alternatives":["Monica Woloshin"],"block_key":"m woloshin","works_api_url":"https://api.openalex.org/works?filter=author.id:A5073729945","updated_date":"2026-10-10T12:59:14","created_date":"2025-10-10T00:00:00"}